CASEYLIN CHENG: Open Payments
NPI 1205557378 · LOMBARD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 22 payments from 9 companies in 2025. Trend: 2023 $46 · 2024 $37 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $224 |
| ABBVIE INC. | 5 | $193 |
| Exact Sciences Corporation | 2 | $116 |
| Lilly USA, LLC | 3 | $70 |
| Novo Nordisk Inc | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: VRAYLAR, REPATHA, The Cologuard Plus Collection Kit, MOUNJARO, Ozempic, SPRAVATO, GEMTESA, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
